| Targeted therapy for hepatocellular carcinoma: novel agents on the horizon M Cervello, JA McCubrey, A Cusimano, N Lampiasi, A Azzolina, ... Oncotarget 3 (3), 236, 2012 | 211 | 2012 |
| Molecular mechanisms of sorafenib action in liver cancer cells M Cervello, D Bachvarov, N Lampiasi, A Cusimano, A Azzolina, ... Cell cycle 11 (15), 2843-2855, 2012 | 167 | 2012 |
| Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti … M Notarbartolo, M Cervello, L Dusonchet, A Cusimano, N D'Alessandro Cancer letters 180 (1), 91-101, 2002 | 154 | 2002 |
| Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX‐2 inhibitors D Foderà, N D'ALESSANDRO, A Cusimano, P Poma, M Notarbartolo, ... Annals of the New York Academy of Sciences 1028 (1), 440-449, 2004 | 90 | 2004 |
| Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation A Cusimano, D Balasus, A Azzolina, G Augello, MR Emma, C Di Sano, ... International journal of oncology 51 (2), 533-544, 2017 | 88 | 2017 |
| RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma SM Akula, SL Abrams, LS Steelman, MR Emma, G Augello, A Cusimano, ... Expert Opinion on Therapeutic Targets 23 (11), 915-929, 2019 | 73 | 2019 |
| Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: a narrative review of preclinical studies MR Emma, G Augello, V Di Stefano, A Azzolina, L Giannitrapani, ... International journal of molecular sciences 22 (3), 1234, 2021 | 66 | 2021 |
| Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells A Cusimano, A Azzolina, JL Iovanna, D Bachvarov, JA McCubrey, ... Cell cycle 9 (7), 1399-1410, 2010 | 63 | 2010 |
| The role of GSK-3 in cancer immunotherapy: GSK-3 inhibitors as a new frontier in cancer treatment G Augello, MR Emma, A Cusimano, A Azzolina, G Montalto, JA McCubrey, ... Cells 9 (6), 1427, 2020 | 62 | 2020 |
| Antitumor effects of the novel NF-κB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation … P Poma, M Notarbartolo, M Labbozzetta, R Sanguedolce, A Alaimo, ... International Journal of Oncology 28 (4), 923-930, 2006 | 61 | 2006 |
| Nanoalgosomes: Introducing extracellular vesicles produced by microalgae G Adamo, D Fierli, DP Romancino, S Picciotto, ME Barone, A Aranyos, ... Journal of extracellular vesicles 10 (6), e12081, 2021 | 58 | 2021 |
| Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells M Cervello, D Bachvarov, N Lampiasi, A Cusimano, A Azzolina, ... PloS one 8 (6), e65569, 2013 | 58 | 2013 |
| Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway A Cusimano, D Foderà, N D'Alessandro, N Lampiasi, A Azzolina, ... Cancer biology & therapy 6 (9), 1457-1464, 2007 | 58 | 2007 |
| WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration J Yang, A Cusimano, JK Monga, ME Preziosi, F Pullara, G Calero, R Lang, ... The American journal of pathology 185 (8), 2194-2205, 2015 | 52 | 2015 |
| Isolation of extracellular vesicles from microalgae: towards the production of sustainable and natural nanocarriers of bioactive compounds S Picciotto, ME Barone, D Fierli, A Aranyos, G Adamo, D Božič, ... Biomaterials Science 9 (8), 2917-2930, 2021 | 51 | 2021 |
| New landscapes and horizons in hepatocellular carcinoma therapy M Cervello, MR Emma, G Augello, A Cusimano, L Giannitrapani, M Soresi, ... Aging (Albany NY) 12 (3), 3053, 2020 | 46 | 2020 |
| Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma M Cervello, G Augello, A Cusimano, MR Emma, D Balasus, A Azzolina, ... Advances in biological regulation 65, 59-76, 2017 | 46 | 2017 |
| Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma G Augello, MR Emma, A Cusimano, A Azzolina, S Mongiovì, R Puleio, ... International journal of cancer 144 (10), 2613-2624, 2019 | 43 | 2019 |
| Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells G Augello, M Modica, A Azzolina, R Puleio, G Cassata, MR Emma, ... Cell death & disease 9 (2), 28, 2018 | 43 | 2018 |
| COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells M Cervello, D Bachvarov, A Cusimano, F Sardina, A Azzolina, N Lampiasi, ... Omics: a journal of integrative biology 15 (6), 383-392, 2011 | 40 | 2011 |
